Clinical Trial Update: Minocycline in MS: Confirmation of Benefit [Phase 3]

View source ↗

Summary

Phase 3 trial investigating minocycline for multiple sclerosis and clinically isolated syndrome; the study is terminated after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: University of Calgary | Conditions: Multiple Sclerosis, Clinically Isolated Syndrome | Phase 3 | Status: TERMINATED